The Healthcare Edge — March 9, 2026

Nebraska will be the first state in the nation to enforce Medicaid work requirements — starting May 1, eight months ahead of the federal deadline. Able-bodied adults ages 19-64 must log 80 hours per month of work, education, or community service to keep coverage. Idaho, Indiana, Iowa, Montana, and New Hampshire have all signed legislation to follow. CMS must issue implementation guidance by June 1. States must conduct member outreach between June 30 and August 31. The operational lift — new eligibility systems, data sharing infrastructure, enrollee verification — is enormous, and the timeline leaves almost no margin. Every Medicaid-dependent provider should be modeling the patient volume hit now, not when the notices start going out.

The downstream layoffs are already starting. L.A. Care Health Plan is cutting 225 employees — 3% of its workforce — by March 13, driven directly by Medi-Cal budget reductions. L.A. Care serves 2.6 million low-income Angelenos, making it the nation's largest publicly operated health plan. Alameda Health System deferred its own layoffs while the county explores options — the "Big Beautiful Bill" Medicaid cuts are hitting California safety-net systems first and hardest. In Nevada, Boulder City Hospital is laying off 70 workers and ending all stays longer than 24 hours as it converts to a rural emergency hospital. In New York, Erie County Medical Center cut 150 positions. The pattern is clear: Medicaid contraction is producing a rolling wave of workforce reductions from coast to coast.

CMS is simultaneously tightening the fraud aperture. The new CRUSH anti-fraud initiative — Comprehensive Regulations to Uncover Suspicious Healthcare — froze all new Medicare enrollment for durable medical equipment suppliers in a six-month nationwide moratorium. CMS stopped $1.5 billion in suspected fraudulent DME billing last year. Comments on the CRUSH request for information are due March 30. For legitimate DME suppliers: the moratorium blocks new entrants but doesn't touch existing providers — your competitive position just improved if you're already enrolled.

The nutrition-industrial complex is getting a federal overhaul. HHS Secretary Kennedy and USDA Secretary McMahon are pushing medical schools to commit to 40 hours of nutrition education, with 31 states now participating. Eighteen states will block SNAP purchases of candy and sugary drinks in 2026, after USDA approved waivers in December. Food companies are already capitulating: PepsiCo and J.M. Smucker are phasing out synthetic dyes ahead of anticipated bans. The MAHA agenda is moving from rhetoric to regulation faster than most health systems have adjusted their cafeteria contracts.

Pharmacy middlemen just lost their cover. The Consolidated Appropriations Act signed February 3 includes sweeping PBM reform: an "any willing pharmacy" provision in 2028 opening networks to every pharmacy that meets standard terms, mandatory semiannual transparency reports on rebates and spread pricing, and a flat-fee compensation requirement that kills rebate-linked incentives for PBMs to favor high-list-price drugs. DOL has a proposed PBM transparency rule with a March 31 comment deadline. For dental practices: your pharmacy costs are driven by PBM formulary design — these changes will reshape which drugs are covered and at what price within 24 months.

In dental, the AI integration cycle is accelerating from one-offs to fleet-wide deployments. Aspen Dental rolled out VideaHealth's Clinical Assist AI across all 1,100+ practices in six weeks — one of the largest clinical AI implementations in the industry. Same-day manufacturing paired with AI-driven implant planning is cutting a process that used to take weeks into a single visit. The DSO deal market is coming back, but not like before: acquirers are favoring operational integration over announcement-driven growth, and some DSOs may face financial workouts in 2026. The dental hygienist shortage is pushing the industry toward teledentistry and AI automation — not as replacement, but as a force multiplier for the providers who remain.

McKesson posted $106.2 billion in Q3 revenue, up 11% year-over-year, and raised full-year adjusted EPS guidance to $38.80-$39.20 — a 17-19% growth clip. Prescription volume from retail national accounts and oncology distribution drove the beat. For the distribution oligopoly, volume growth from specialty drugs and biosimilars is overwhelming the margin pressure from Medicaid contraction. Meanwhile, one bright spot in population health: U.S. maternal mortality fell to 17.9 per 100,000 births in 2024, the lowest since 2018 — evidence that targeted investment in maternal health is actually working.

Medicaid work requirements are here. Layoffs are cascading. PBM reform is law. Nutrition policy is being rewritten. And the dental AI race just went from pilot programs to fleet-wide deployment at 1,100 practices in six weeks. The organizations that are modeling these disruptions now — not reacting to them in Q3 — will be the ones still standing when the dust settles.

Capital Pulse — Our weekly healthcare market review is live. Payers cratered on Elevance CMS sanctions, behavioral health and healthcare IT surged on earnings beats, and dental went risk-off. 28 tickers, 4 sectors, one sharp take.

DSO Deal Tracker — 3,200+ dental & healthcare M&A transactions tracked since 2016. Filter by year, state, acquirer type, and sector. Updated daily.

Built by the team behind Praxis AI — intelligence for modern healthcare.